OMCL Stock Analysis: Buy, Sell, or Hold?
OMCL - Omnicell Inc
$43.36
0.19 (0.44%)
▲
5d:
+0.07%
30d:
+15.53%
90d:
+19.85%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Apr 28, 2026
0d
Get Alerted When OMCL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: OMCL shows positive signals but monitor for confirmation. Market pricing in 1.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: OMCL shows positive signals but monitor for confirmation. Market pricing in 1.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$68.31
Based on 8.7% avg growth
INTRINSIC VALUE TODAY
$42.41
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OMCL is currently trading at $43.36, which is considered extended relative to its 30-day fair value range of $35.81 to $43.20. The stock's valuation (Forward PE: 19.7) is in line with its historical norms (20.6). Remarkably, the market is currently pricing in an annual earnings decline of 1.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OMCL is in a strong downtrend. Immediate support is located at $41.23, while resistance sits at $44.97.
Market Sentiment: OMCL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $61.29 (+42.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OMCL is in a strong downtrend. Immediate support is located at $41.23, while resistance sits at $44.97.
Market Sentiment: OMCL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $61.29 (+42.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$35.81 -
$43.20
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 42.0% below Wall St target ($61.29)
Trading Range Analysis
30-Day Trading Range
$35.81 -
$43.20
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$41.23
Resistance Level
$44.97
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.67
Wall Street Target
$61.29
(+42.0%)
Revenue Growth (YoY)
14.9%
Earnings Growth (YoY)
-35.9%
Profit Margin
1.7%
Valuation Discount vs History
-1.5% cheaper
PE vs Historical
19.7 vs 20.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.5%
(market-implied from PE analysis)
1-Year Target
$42.52
(-2%)
2-Year Target
$41.88
(-3%)
3-Year Target
$41.26
(-4%)
3-Yr Target (if PE normalizes)
(PE: 20→21)
$43.21
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 13.3%)
$70.34
(+63%)
Base:
(SPY PE: 19.7, Growth: 13.3%)
$62.77
(+45%)
Bear:
(PE: 16.7, Growth: 13.3%)
$53.36
(+24%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Forward PE: 29.50 | Forward EPS (Implied): $1.46
Bull Case
$52.13
(+21%)
Analyst growth 15.0%, PE expands to 31.0
Base Case
$43.17
(0%)
Market implied 0.0%, PE stable at 29.5
Bear Case
$33.03
(-24%)
Severe decline -15.0%, PE contracts to 26.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.7 to 20.6
Stabilization Target:
$45.22
(+4.7%)
PE Expansion Potential:
+4.7%
Share & Embed Analysis
Last updated: May 14, 2026 3:40 PM ET
Data refreshes hourly during market hours. Next update: 4:40 PM
Data refreshes hourly during market hours. Next update: 4:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OMCL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Corey J Manley
SELL
7405 shares
2026-03-16
Corey J Manley
SELL
6106 shares
2026-01-08
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$264 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$16 | 54 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$5 | 60 HOLD |
